In Vitro Fertilization Outcomes in Metabolic Syndrome

N/ACompletedNCT01958424

Meir Medical Center30 enrolled

Overview

The purpose of this study is to examine the effect of metabolic syndrome in over-weight women on IVF treatment outcomes.

This porpuse of the study is to examine the physiology of CRP during the IVF cycle in and to evaluated the effect of CRP in patient with and without metabolic syndrome on IVF outcomes

Study Type

OBSERVATIONAL

Enrollment

Conditions

Metabolic Syndrome

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * women undergoing ivf treatment Exclusion Criteria: * inflammatory disease * acute conditions

Locations (1)

Sapir Medical Center, Meir Hospital

Kfar Saba, Israel, Israel

Outcomes

Primary Outcomes

success or failure of ivf treatment

success or failure of a treatment will be determined by beta-Human chorionic gonadotropin test, number of oocyte retrieved or fertilized and embryos quality.

Time frame: within 1 year from intiation of ivf treatment

Secondary Outcomes

blood levels of C-reactive protein

Time frame: within 1 year from initiation of ivf treatment

follicle liquid levels of C-reactive protein

Time frame: within 1 year from initiation of ivf treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.